Advances in Nuclear Medicine and Molecular Imaging
Advances in Nuclear Medicine and Molecular Imaging features fourteen internationally renowned faculty experts discussing nuclear medicine’s latest trends and emerging procedures. Created from the Mid-Eastern Chapter of the Society of Nuclear Medicine and Molecular Imaging’s 52nd Annual Conference, this activity presents the impact of radiopharmaceuticals on imaging, cardiology, oncology and much more. Robust discussions of imaging tools, administration equipment, dosimetry and future applications are included, as well. Worth 15 AMA PRA Category I Credits™, Advances in Nuclear Medicine and Molecular Imaging meets Nuclear Medicine/PET accreditation requirements and provides an essential update for all physicians and technologists involved with this area of medicine.
Cost: $595.00Add to cart
Key Features
From the Society of Nuclear Medicine and Molecular Imaging Mid-East Chapter. 15 AMA PRA Category I Credits™ Meets Nuclear Medicine/Pet Accreditation Requirements.
Topics Covered
Cardiac applications, myocardial imaging, dosimetry, theranostics, radiotracer based bone scanning, lymphoma staging, PET applications for glioblastoma, thyroid cancer and prostate cancer, SPECT-CT, radiation safety, artificial intelligence, emerging radiopharmaceuticals and much more.
Learning Objectives
After completing this activity, the participant should be better able to:
1. Discuss the value of quantitative myocardial blow flow and myocardial blood flow reserve, including nuclear medicine’s role in measuring same.
2. Describe the potential of dosimetry to optimize radiopharmaceutical therapy.
3. Explain current applications and potential opportunities for positron emission topography (PET) in oncologic imaging.
4. Discuss strategies to achieve the lowest possible radiation dose for PET imaging.
5. Describe current and emerging radiopharmaceuticals in theranostics.
Target Audience
The educational design of this activity addresses the needs of nuclear medicine physicians, technologists, radiologists, oncologists, cardiologists and other medical professionals who use radionuclides in the care of patients.
Additional credit info
Release date: October 4, 2024
CME Expiration: October 3, 2027